rs920471641
Variant names: 
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_052945.4(TNFRSF13C):c.132A>G(p.Lys44Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,459,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000053   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  7.6e-7   (  0   hom.  ) 
Consequence
 TNFRSF13C
NM_052945.4 synonymous
NM_052945.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.739  
Publications
0 publications found 
Genes affected
 TNFRSF13C  (HGNC:17755):  (TNF receptor superfamily member 13C) B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival. [provided by RefSeq, Jul 2008] 
TNFRSF13C Gene-Disease associations (from GenCC):
- common variable immunodeficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- immunodeficiency, common variable, 4Inheritance: AR, Unknown Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 22-41926642-T-C is Benign according to our data. Variant chr22-41926642-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 538824.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.739 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000526  AC: 8AN: 151972Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
8
AN: 
151972
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  7.65e-7  AC: 1AN: 1307292Hom.:  0  Cov.: 32 AF XY:  0.00000155  AC XY: 1AN XY: 644092 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1307292
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
644092
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
26380
American (AMR) 
 AF: 
AC: 
0
AN: 
25174
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
22890
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
28054
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
71306
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
32734
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
3866
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1042878
Other (OTH) 
 AF: 
AC: 
1
AN: 
54010
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000526  AC: 8AN: 151972Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74238 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
8
AN: 
151972
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74238
show subpopulations 
African (AFR) 
 AF: 
AC: 
8
AN: 
41400
American (AMR) 
 AF: 
AC: 
0
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10562
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
314
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
67958
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.438 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Immunodeficiency, common variable, 4    Benign:1 
Aug 07, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.